OTC Markets EXMKT - Delayed Quote USD
Aridis Pharmaceuticals, Inc. (ARDS)
At close: November 6 at 3:34 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| HAMILTON JOHN F Director | Conversion of Exercise of derivative security | Jun 5, 2023 | 5,000 |
| JAFRI HASAN Officer | Conversion of Exercise of derivative security | Jun 5, 2023 | 15,100 |
| KURLAND FRED F Chief Financial Officer | Conversion of Exercise of derivative security | Jun 5, 2023 | 4,000 |
| PATZER ERIC Director | Purchase | Jun 24, 2024 | 884,600 |
| TRUONG VU Chief Executive Officer | Purchase | Jun 24, 2024 | 1,378,640 |
| WINDHAM-BANNISTER SUSAN RICHARDS Director | Conversion of Exercise of derivative security | Jun 5, 2023 | 5,000 |
Related Tickers
ONPPF Oncopeptides AB (publ)
0.2650
0.00%
AS0.F European Medical Solutions
0.0134
-2.90%
ORMP.TA Oramed Pharmaceuticals Inc.
892.40
+0.95%
APTA.L Aptamer Group plc
0.2300
+4.55%
ELVAF Evolva Holding SA
0.9500
0.00%
FLERIE.ST Flerie AB (publ)
44.47
-1.32%
NBCO Neon Bloom, Inc.
0.0265
-30.08%
LCTX.TA Lineage Cell Therapeutics, Inc.
325.70
+0.68%
HAVLF HAVN Life Sciences Inc.
0.0001
0.00%
ANEB Anebulo Pharmaceuticals, Inc.
1.8700
+1.63%